The effect of hydrodynamics-based delivery of an IL-13-Ig fusion gene for experimental autoimmune myocarditis in rats and its possible mechanism

European Journal of Immunology

Volumn 35, Issue 6, 2005, Pages 1995-2005

  Elnaggar, Raafat ^a   Hanawa, Haruo ^a   Liu, Hui ^a   Yoshida, Tsuyoshi ^a   Hayashi, Manabu ^a   Watanabe, Ritsuo ^a   Abe, Satoru ^a   Toba, Ken ^a   Yoshida, Kaori ^a   Chang, He ^a   Minagawa, Shiro ^a   Okura, Yuji ^a   Kato, Kiminori ^a   Kodama, Makoto ^a   Maruyama, Hiroki ^a   Miyazaki, Junichi ^b   Aizawa, Yoshifusa ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Autoimmune; Dilated cardiomyopathy; Gene therapy; IL 13; Immune system; Myocarditis

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CYCLOOXYGENASE 2; IMMUNOGLOBULIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR; INTERLEUKIN 1BETA; MESSENGER RNA; PROSTAGLANDIN SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; BODY WEIGHT; CONTROLLED STUDY; DISEASE CONTROL; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ENDOTHELIUM CELL; FIBROBLAST; GENE EXPRESSION; HEART FAILURE; HEART WEIGHT; HYDRODYNAMICS; IMMUNIZATION; MYOCARDITIS; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; TARGET CELL;

ANIMALS; ANTIGENS, CD11B; AUTOIMMUNE DISEASES; CELLS, CULTURED; GENE THERAPY; INTERLEUKIN-13; INTERLEUKIN-13 RECEPTOR ALPHA1 SUBUNIT; MYOCARDITIS; PLASMIDS; RATS; RATS, INBRED LEW; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-13; RECEPTORS, INTERLEUKIN-4; RECOMBINANT FUSION PROTEINS; RNA, MESSENGER;

EID: 20844443359     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200425776     Document Type: Article

References (41)

1. Kodama, M., Matsumoto, Y., Fujiwara, M., Zhang, S. S., Hanawa, H., Itoh, E., Tsuda, T., Izumi, T. and Shibata, A., Characteristics of giant cells and factors related to the formation of giant cells in myocarditis. Circ. Res. 1991. 69: 1042-1050.
2. Kodama, M., Matsumoto, Y. and Fujiwara, M., In vivo lymphocyte-mediated myocardial injuries demonstrated by adoptive transfer of experimental autoimmune myocarditis. Circulation 1992. 85: 1918-1926.
3. Hanawa, H., Abe, S., Hayashi, M., Yoshida, T., Yoshida, K., Shiono, T., Fuse, K., Ito, M., Tachikawa, H., Kashimura, T. et al., Time course of gene expression in rat experimental autoimmune myocarditis. Clin. Sci. 2002. 103: 623-632.
4. Yang, Z., Chen, M., Wu, R., Fialkow, L. B., Bromberg, J. S., McDuffie, M., Naji, A. and Nadler, J. L., Suppression of autoimmune diabetes by viral IL-10 gene transfer. J. Immunol. 2002. 168: 6479-6485.
5. Goudy, K., Song, S., Wasserfall, C., Zhang, Y. C., Kapturczak, M., Muir, A., Powers, M., Scott-Jorgensen, M., Campbell-Thompson, M., Crawford, J. M. et al., Adeno-associated virus vector-mediated IL-10 gene delivery prevents type 1 diabetes in NOD mice. Proc. Natl. Acad. Sci. USA 2001. 98: 13913-13918.
6. Watanabe, K., Nakazawa, M., Fuse, K., Hanawa, H., Kodama, M., Aizawa, Y., Ohnuki, T., Gejyo, F., Maruyama, H. and Miyazaki, J., Protection against autoimmune myocarditis by gene transfer of interleukin-10 by electroporation. Circulation 2001. 104: 1098-1100.
7. Dolganov, G., Bort, S., Lovett, M., Burr, J., Schubert, L., Short, D., McGurn, M., Gibson, C. and Lewis, D. B., Coexpression of the interleukin-13 and interleukin-4 genes correlates with their physical linkage in the cytokine gene cluster on human chromosome 5q23-31. Blood 1996. 87: 3316-3326.
8. Mueller, T. D., Zhang, J. L., Sebald, W. and Duschl, A., Structure, binding, and antagonists in the IL-4/IL-13 receptor system. Biochim. Biophys. Acta 2002. 1592: 237-250.
9. Zurawski, S. M., Vega, F., Jr., Huyghe, B. and Zurawski, G., Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction. EMBO J. 1993. 12: 2663-2670.
10. Callard, R. E., Matthews, D. J. and Hibbert, L., IL-4 and IL-13 receptors: are they one and the same? Immunol. Today 1996. 17: 108-110.
11. de Waal Malefyt, R., Figdor, C. G., Huijbens, R., Mohan-Peterson, S., Bennett, B., Culpepper, J., Dang, W., Zurawski, G. and de Vries, J. E., Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10. J. Immunol. 1993. 151: 6370-6381.
12. Alaaeddine, N., Di Battista, J. A., Pelletier, J. P., Kiansa, K., Cloutier, J. M. and Martel-Pelletier, J., Inhibition of tumor necrosis factor alpha-induced prostaglandin E2 production by the antiinflammatory cytokines interleukin-4, interleukin-10, and interleukin-13 in osteoarthritic synovial fibroblasts: distinct targeting in the signaling pathways. Arthritis Rheum. 1999. 42: 710-718.
13. Punnonen, J., Aversa, G., Cocks, B. G., McKenzie, A. N., Menon, S., Zurawski, G., de Waal Malefyt, R. and de Vries, J. E., Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc. Natl. Acad. Sci. USA 1993. 90: 3730-3734.
14. Woods, J. M., Amin, M. A., Katschke, K. J., Jr., Volin, M. V., Ruth, J. H., Connors, M. A., Woodruff, D. C., Kurata, H., Arai, K., Haines, G. K., 3rd. et al., Interleukin-13 gene therapy reduces inflammation, vascularization, and bony destruction in rat adjuvant-induced arthritis. Hum. Gene Ther. 2002. 13: 381-393.
15. Liu, F., Song, Y. and Liu, D., Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther. 1999. 6: 1258-1266.
16. Maruyama, H., Higuchi, N., Nishikawa, Y., Kameda, S., Iino, N., Kazama, J. J., Takahashi, N., Sugawa, M., Hanawa, H., Tada, N. et al., High-level expression of naked DNA delivered to rat liver via tail vein injection. J. Gene Med. 2002. 4: 333-341.
17. Higuchi, N., Maruyama, H., Kuroda, T., Kameda, S., Iino, N., Kawachi, H., Nishikawa, Y., Hanawa, H., Tahara, H., Miyazaki, J. et al., Hydrodynamics-based delivery of the viral interleukin-10 gene suppresses experimental crescentic glomerulonephritis in Wistar-Kyoto rats. Gene Ther. 2003. 10: 1297-1310.
18. Jiang, J., Yamato, E. and Miyazaki, J., Sustained expression of Fc-fusion cytokine following in vivo electroporation and mouse strain differences in expression levels. J. Biochem. (Tokyo) 2003. 133: 423-427.
19. Hanawa, H., Watanabe, R., Hayashi, M., Yoshida, T., Abe, S., Komura, S., Liu, H., Elnaggar, R., Chang, H., Okura, Y. et al., A novel method to assay proteins in blood plasma after intravenous injection of plasmid DNA. Tohoku J. Exp. Med. 2004. 202: 155-161.
20. Bogdan, C., Thuring, H., Dlaska, M., Rollinghoff, M. and Weiss, G., Mechanism of suppression of macrophage nitric oxide release by IL-13: influence of the macrophage population. J. Immunol. 1997. 159: 4506-4513.
21. Cash, E., Minty, A., Ferrara, P., Caput, D., Fradelizi, D. and Rott, O., Macrophage-inactivating IL-13 suppresses experimental autoimmune encephalomyelitis in rats. J. Immunol. 1994. 153: 4258-4267.
22. Furlan, R., Poliani, P. L., Marconi, P. C., Bergami, A., Ruffini, F., Adorini, L., Glorioso, J. C., Comi, G. and Martino, G., Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice. Gene Ther. 2001. 8: 13-19.
23. Afanasyeva, M., Wang, Y., Kaya, Z., Park, S., Zilliox, M. J., Schofield, B. H., Hill, S. L. and Rose, N. R., Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype. Am. J. Pathol. 2001. 159: 193-203.
24. Hesse, M., Bayrak, S. and Mitchison, A., Protective major histocompatibility complex genes and the role of interleukin-4 in collagen-induced arthritis. Eur. J. Immunol. 1996. 26: 3234-3237.
25. Zurawski, G. and de Vries, J. E., Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol. Today 1994. 15: 19-26.
26. Doucet, C., Brouty-Boye, D., Pottin-Clemenceau, C., Jasmin, C., Canonica, G. W. and Azzarone, B., IL-4 and IL-13 specifically increase adhesion molecule and inflammatory cytokine expression in human lung fibroblasts. Int. Immunol. 1998. 10: 1421-1433.
27. Wynn, T. A., IL-13 effector functions. Annu. Rev. Immunol. 2003. 21: 425-456.
28. Kodama, M., Zhang, S., Hanawa, H. and Shibata, A., Immunohistochemical characterization of infiltrating mononuclear cells in the rat heart with experimental autoimmune giant cell myocarditis. Clin. Exp. Immunol. 1992. 90: 330-335.
29. Hirono, S., Islam, M. O., Nakazawa, M., Yoshida, Y., Kodama, M., Shibata, A., Izumi, T. and Imai, S., Expression of inducible nitric oxide synthase in rat experimental autoimmune myocarditis with special reference to changes in cardiac hemodynamics. Circ. Res. 1997. 80: 11-20.
30. Heim, A., Zeuke, S., Weiss, S., Ruschewski, W. and Grumbach, I. M., Transient induction of cytokine production in human myocardial fibroblasts by coxsackievirus B3. Circ. Res. 2000. 86: 753-759.
31. Morgan, M. P., Whelan, L. C., Sallis, J. D., McCarthy, C. J., Fitzgerald, D. J. and McCarthy, G. M., Basic calcium phosphate crystal-induced prostaglandin E2 production in human fibroblasts: role of cyclooxygenase 1, cyclooxygenase 2, and interleukin-1beta. Arthritis Rheum. 2004. 50: 1642-1649.
32. Eghbali, M., Czaja, M. J., Zeydel, M., Weiner, F. R., Zern, M. A., Seifter, S. and Blumenfeld, O. O., Collagen chain mRNAs in isolated heart cells from young and adult rats. J. Mol. Cell. Cardiol. 1988. 20: 267-276.
33. Westman, M., Korotkova, M., af Klint, E., Stark, A., Audoly, L. P., Klareskog, L., Ulfgren, A. K. and Jakobsson, P. J., Expression of microsomal prostaglandin E synthase 1 in rheumatoid arthritis synovium. Arthritis Rheum. 2004. 50: 1774-1780.
34. Gabay, C., Porter, B., Guenette, D., Billir, B. and Arend, W. P., Interleukin-4 (IL 4) and IL-13 enhance the effect of IL-1beta on production of IL-1 receptor antagonist by human primary hepatocytes and hepatoma HepG2 cells: differential effect on C-reactive protein production. Blood 1999. 93: 1299-1307.
35. Kolios, G., Rooney, N., Murphy, C. T., Robertson, D. A. and Westwick, J., Expression of inducible nitric oxide synthase activity in human colon epithelial cells: modulation by T lymphocyte derived cytokines. Gut 1998. 43: 56-63.
36. Saito, A., Okazaki, H., Sugawara, I., Yamamoto, K. and Takizawa, H., Potential action of IL-4 and IL-13 as fibrogenic factors on lung fibroblasts in vitro. Int. Arch. Allergy Immunol. 2003. 132: 168-176.
37. Maruyama, H., Higuchi, N., Nishikawa, Y., Hirahara, H., Iino, N., Kameda, S., Kawachi, H., Yaoita, E., Gejyo, F. and Miyazaki, J., Kidney-targeted naked DNA transfer by retrograde renal vein injection in rats. Hum. Gene Ther. 2002. 13: 455-468.
38. Hou, D., Maclaughlin, F., Thiesse, M., Panchal, V. R., Bekkers, B. C., Wilson, E. A., Rogers, P. I., Coleman, M. C. and March, K. L., Widespread regional myocardial transfection by plasmid encoding Del-1 following retrograde coronary venous delivery. Catheter. Cardiovasc. Interv. 2003. 58: 207-211.
39. Kodama, M., Matsumoto, Y., Fujiwara, M., Masani, F., Izumi, T. and Shibata, A., A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction. Clin. Immunol. Immunopathol. 1990. 57: 250-262.
40. Nishino, T., Kodaira, T., Shin, S., Imagawa, K., Shima, K., Kumahara, Y., Yanaihara, C. and Yanaihara, N., Glucagon radioimmunoassay with use of antiserum to glucagon C-terminal fragment. Clin. Chem. 1981. 27: 1690-1697.
41. Isenberg, G. and Klockner, U., Calcium tolerant ventricular myocytes prepared by preincubation in a "KBmedium". Pflugers Arch. 1982. 395: 6-18.